DRTS (Alpha Tau Medical) Net Margin %: 0.00% (As of Mar. 2026)


DRTS Alpha Tau Medical Ltd DRTS
32 GF Score
Price $13.22
! 3 Warning Signs
View Full Analysis

What is Alpha Tau Medical Net Margin %?

Alpha Tau Medical DRTS +4.67% 32 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates DRTS with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 940 Biotechnology companies, Alpha Tau Medical ranks worse than 106382.87% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Alpha Tau Medical's Net Income for the three months ended in Mar. 2026 was $-22.94 Mil. Alpha Tau Medical's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Alpha Tau Medical's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Alpha Tau Medical's Net Margin % or its related term are showing as below:


DRTS's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.295
* Ranked among companies with meaningful Net Margin % only.

Alpha Tau Medical  (NAS:DRTS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Alpha Tau Medical Net Margin % Related Terms


Alpha Tau Medical Net Margin % Historical Data

* Premium members only.

The historical data trend for Alpha Tau Medical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Tau Medical Net Margin % Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Alpha Tau Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DRTS vs ORIC, OLMA, KURA: Net Margin % Comparison

For the Biotechnology subindustry, Alpha Tau Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's Net Margin % falls into.


DRTS
32GF Score
Alpha Tau Medical Ltd DRTS
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Tau Medical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Alpha Tau Medical's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-42.627/0
= %

Alpha Tau Medical's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-22.939/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Alpha Tau Medical (DRTS) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Alpha Tau Medical and its competitors. According to the industry distribution chart, Alpha Tau Medical ranks #999999 out of 940 companies in the Biotechnology industry.
Is Alpha Tau Medical's Net Margin % too high?
Alpha Tau Medical's current Net Margin % is 0.00%. Based on the distribution chart, Alpha Tau Medical ranks #999999 out of 940 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alpha Tau Medical has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Tau Medical's Net Margin % compare to ORIC and OLMA?
According to the Biotechnology industry distribution chart, Alpha Tau Medical ranks #999999 out of 940 companies for Net Margin %. This places Alpha Tau Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Alpha Tau Medical and its competitors. Alpha Tau Medical's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Tau Medical stock overvalued right now?
Alpha Tau Medical (DRTS) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Alpha Tau Medical's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Alpha Tau Medical (DRTS), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Tau Medical Business Description

Address Kiryat HaMada Street 5, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
32GF Score

Get the complete analysis for DRTS

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.22
Price